“orbimed-advisors” Archives

in
Entry Author Date Location
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More 10/26/18 National
TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push 10/19/18 San Diego
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
OrbiMed Founder Isaly Steps Down After Sexual Harassment Report 12/08/17 New York
Report: Sexual Harassment Claims Hit OrbiMed Founder Sam Isaly 12/06/17 New York
SpringWorks Spins Out of Pfizer With $103M to Give Shelved Drugs New Life 09/25/17 New York
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More 08/11/17 National
For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY 08/09/17 New York
Not Resting on Hemophilia Biz, Bioverativ Pays $400M For True North 05/23/17 Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis 04/26/17 Boston
Ex-Dendreon CEO, Gold, Returns to Wall Street as Alpine, Nivalis Merge 04/18/17 Seattle
Aiming At P53, Cancer’s Hard Target, PMV Pharma Raises $74M 02/22/17 New York
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Retooled Selecta Bio Takes Crossover Cash to IPO Queue 05/24/16 Boston
West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More 01/29/16 San Diego
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells 01/27/16 San Francisco
Exosome Diagnostics Closes $60M Series B for Liquid Biopsy Test 01/07/16 Boston
With $100M, Guardant Health to Expand Reach of Blood Test for Cancer 01/07/16 San Francisco
Bristol-Myers to Add Cardioxyl’s Heart Failure Drug With $300M Deal 11/02/15 Raleigh Durham
Alector Raises $32M For Immune-Based Neuro Drug Development 09/16/15 San Francisco
Avitide Gets $7.6M More to Purify Complex Biologics 08/06/15 Boston
Gene Therapy Upstart Dimension Nabs $65M From “Crossover” Backers 04/21/15 Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor 04/14/15 National
West Coast Biotech Roundup: Juno, Tekmira, True North, aTyr & More 04/10/15 Seattle
With $35M Infusion, True North Moves Rare Disease Drug Into Clinic 04/07/15 San Francisco
Prenatal Screener Natera Grabs $55M, Considers Cancer Test 04/06/15 San Francisco
Tricida Grabs $30M Series B for Chronic Kidney Disease Treatment 03/04/15 San Francisco
East Coast Biotech Roundup: Raze, Retrophin, Alnylam, & More 10/16/14 Boston
Selecta, Sharpening Focus, Gets $20M More to Make Biologics Safer 10/15/14 Boston
Page 1 of 6 next page »

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Carbonite
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

© 2007-2018, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.